Yousif Capital Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$327K Buy
18,204
+62
+0.3% +$867 ﹤0.01% 1474
2026
Q1
$171K Sell
18,142
-332
-2% -$3.65K ﹤0.01% 1794
2025
Q4
$222K Sell
18,474
-2,614
-12% -$34.8K ﹤0.01% 1750
2025
Q3
$302K Sell
21,088
-4,202
-17% -$57.6K ﹤0.01% 1648
2025
Q2
$310K Buy
25,290
+4
+0% +$58 ﹤0.01% 1660
2025
Q1
$556K Sell
25,286
-476
-2% -$11.2K 0.01% 1394
2024
Q4
$584K Sell
25,762
-906
-3% -$19.8K 0.01% 1415
2024
Q3
$485K Sell
26,668
-1,220
-4% -$28.3K 0.01% 1509
2024
Q2
$813K Sell
27,888
-3,725
-12% -$110K 0.01% 1245
2024
Q1
$1.12M Sell
31,613
-683
-2% -$27.3K 0.01% 1150
2023
Q4
$1.41M Sell
32,296
-1,153
-3% -$45.4K 0.02% 1031
2023
Q3
$1.28M Sell
33,449
-2,110
-6% -$88.8K 0.02% 1004
2023
Q2
$1.46M Sell
35,559
-1,865
-5% -$89.8K 0.02% 949
2023
Q1
$2.15M Sell
37,424
-80
-0.2% -$4.51K 0.03% 720
2022
Q4
$2.1M Buy
37,504
+262
+0.7% +$13.3K 0.03% 726
2022
Q3
$1.58M Sell
37,242
-3,045
-8% -$156K 0.02% 899
2022
Q2
$2.18M Buy
40,287
+80
+0.2% +$4.8K 0.03% 760
2022
Q1
$2.58M Buy
40,207
+2,466
+7% +$162K 0.03% 757
2021
Q4
$2.53M Buy
+37,741
New +$2.55M 0.03% 807

Other funds holding IART

Yousif Capital Management's IART Position: Q2 2026 in Review

Yousif Capital Management increased its Integra LifeSciences (IART) stake by 0.34% in Q2 2026, buying an estimated $867 and bringing the position to 18,204 shares worth $327K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Yousif Capital Management first reported a position in IART in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.58M in Q1 2022. 16 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Yousif Capital Management held 18,204 shares of Integra LifeSciences worth $327K as of Q2 2026.
  • Yousif Capital Management bought 62 Integra LifeSciences shares in Q2 2026, an estimated $867.
  • Integra LifeSciences made up ﹤0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1474 holding.
  • Yousif Capital Management first reported a position in Integra LifeSciences in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Integra LifeSciences position peaked at $2.58M in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.